The Effervescent Tablet Market is witnessing significant growth due to the rising trend of dietary supplements for overall health. However, market restraints include high production costs and the need ...
SAN ANTONIO, May 4 /PRNewswire-FirstCall/ -- Results of a Phase 3 clinical trial demonstrate positive results with a fentanyl effervescent buccal tablet (FEBT) in all ...
NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024-2028, according to ...
NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024-2028, according ...
NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024-2028, according ...
Pfizer Inc., GSK plc, Novartis AG, Bayer AG, Perrigo Company plc, Reckitt Benckiser Group PLC, Bristol-Myers Squibb Company, CHIESI SAS, Hermes Pharma, S. G. Biopharm ...
availability of effervescent supplements for youth and children. However, high sodium content in effervescent tablets poses a challenge. Key market players include Alturix Ltd., Bayer AG, Bliss GVS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback